Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer

NCT01376674 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT01376674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01376674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
Not reported
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer